Chinese maker of functional food ingredients such as dietary fiber, resistant dextrin and prebiotics for food/beverage makers.
Chinese maker of functional food ingredients such as dietary fiber, resistant dextrin and prebiotics for food/beverage makers.
In one line: A Chinese food-ingredient specialist, akin to a smaller Tate & Lyle/Ingredion.
Moat: narrow (process know-how, customer qualification). Technical know-how in functional fiber production and qualified relationships with F&B makers.
Headquarters: Yucheng, Shandong, China · Employees: 990
Size Shandong Bailong Chuangyuan Bio-Tech (605016.SS) is a China Consumer Staples company (Food: Specialty/Candy) with a market value of $1.25B, the 1777th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥20.10 on 18 Nov 2026.
Performance Over six months the shares fell 26.2%, against -12.6% for the median peer and -20.0% for the China market (cap-weighted) — 5th lowest of 21 in its peer set.
Growth Revenue grew 19.1% over the last twelve months (peer median +7.1%); the operating margin is 31.6% (peer median 6.1%).
Valuation It trades at 19.1× forward earnings against a peer median of 23.8× (10th cheapest of 20).
Price implies For today's price to make sense, revenue must grow about 9% a year for seven years (Req g). Recent delivered growth is +23%, so the hurdle is -13 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 11.1 points above its cost of capital (8.0% WACC).
Next results Next results expected around 23 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥1.54B | CN¥1.38B | CN¥1.14B | CN¥864M | CN¥719M |
| Revenue growth | — | +21% | +32% | +20% | — |
| Gross profit | CN¥718M | CN¥560M | CN¥367M | CN¥272M | CN¥219M |
| EBITDA | n/a | CN¥536M | CN¥339M | CN¥241M | CN¥194M |
| Net income | CN¥397M | CN¥369M | CN¥246M | CN¥193M | CN¥151M |
| Free cash flow | CN¥9.01M | -CN¥157M | CN¥28.8M | -CN¥109M | -CN¥13.5M |
| Capital expenditure | CN¥598M | CN¥297M | CN¥282M | CN¥312M | CN¥176M |
| Total debt | CN¥682M | CN¥246M | CN¥125M | CN¥29.6M | CN¥12.0M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Shandong Bailong Chuangyuan Bio-Tech 605016.SS | $1.25B | -26% | +19% | 32% | 19.1× | 9.1% |
| Ingredion INGR | $5.60B | -11% | -1% | 11% | 9.3× | -5.6% |
| Tate & Lyle TATE.L | $3.27B | +11% | +2% | 8% | 15.8× | 13.2% |
| COFCO Biotechnology 000930.SZ | $1.23B | -18% | -9% | -2% | n/a | n/a |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 605016.SS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +4.8% | -0.2% | 3rd highest of 21 |
| 6-month return | -26.2% | -12.6% | 5th lowest of 21 |
| Distance from 52-week high | -30.9% | -24.4% | 10th lowest of 21 |
| Revenue growth (TTM) | +19.1% | +7.1% | 5th highest of 21 |
| Operating margin | 31.6% | 6.1% | highest of 21 |
| Forward P/E | 19.1× | 23.8× | 10th cheapest of 20 |
| Growth the price implies (Req g, 7 yrs) | 9.1% | -1.6% | 5th most demanding of 13 |
| Growth delivered (Del g) | +22.5% | +7.7% | 3rd highest of 13 |
| Hurdle (Req g minus delivered) | -13.4 pp | -11.8 pp | 4th least demanding of 13 |
| ROIC minus cost of capital | +11.1 pp | +0.3 pp | 2nd highest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Shandong Bailong Chuangyuan Bio-Tech 605016.SS | China | $1.25B | -26% | +19% | 32% | 19.1× | 9.1% | +22.5% |
| Yantai China Pet Foods 002891.SZ | China | $1.25B | -17% | +21% | 4% | 29.4× | n/a | n/a |
| Nisshin OilliO 2602.T | Japan | $1.25B | +19% | +9% | 4% | 18.6× | n/a | n/a |
| Manorama Industries MANORAMA.NS | India | $1.26B | +36% | +60% | 24% | 36.1× | 32.6% | +46.9% |
| Fufeng 0546.HK | Hong Kong | $1.24B | -36% | +1% | 4% | 7.0× | n/a | n/a |
| Huabao International 0336.HK | Hong Kong | $1.27B | -13% | +13% | 3% | 23.8× | 14.6% | -2.7% |
| Bikaji Foods International BIKAJI.NS | India | $1.28B | -29% | +13% | 9% | 42.4× | 39.9% | +17.5% |
| Lotte 004990.KS | South Korea | $1.21B | -23% | 0% | 1% | 70.0× | n/a | n/a |
| Morinaga & 2201.T | Japan | $1.32B | +1% | +5% | 9% | 12.6× | -5.6% | +7.1% |
| Seneca Foods SENEA | United States | $1.18B | +23% | +12% | 8% | 11.8× | -10.4% | +2.5% |
| Italmobiliare ITM.MI | Italy | $1.17B | -13% | +8% | 14% | 14.0× | n/a | n/a |
| CCL Products (India) CCL.NS | India | $1.36B | -13% | +24% | 13% | 25.4× | 17.8% | +29.1% |
| Qianhe Condiment & Food 603027.SS | China | $1.38B | -18% | -6% | 14% | 24.0× | 2.5% | +8.8% |
| Snowsky Salt Industry 600929.SS | China | $1.14B | -31% | +32% | 1% | 51.8× | n/a | n/a |
| Flowers Foods FLO | United States | $1.11B | -27% | +1% | 6% | 8.2× | -6.6% | +3.7% |
| Star Lake Bioscience 600866.SS | China | $1.07B | -24% | -3% | 0% | 37.4× | n/a | n/a |
| ARIAKE JAPAN 2815.T | Japan | $1.06B | -4% | +5% | 17% | 17.6× | -6.1% | +6.1% |
| Nongshim 004370.KS | South Korea | $1.52B | -10% | +6% | 6% | 11.0× | -17.9% | +5.9% |
| Kagome 2811.T | Japan | $1.54B | +11% | +3% | 7% | 24.8× | 2.6% | +10.0% |
| ORION 001800.KS | South Korea | $1.02B | -7% | +16% | 15% | n/a | -15.9% | +8.3% |
| NIPPN 2001.T | Japan | $1.55B | +10% | +2% | 5% | 11.8× | n/a | n/a |